We rank companies based on fund manager, research analyst and news sentiment
FLGT stock icon

Fulgent Genetics
FLGT

$20.56
0.98%
 

About: Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Employees: 1,012

0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

1,005% more call options, than puts

Call options by funds: $38M | Put options by funds: $3.43M

10% more capital invested

Capital invested by funds: $375M [Q3] → $413M (+$38.2M) [Q4]

1.38% more ownership

Funds ownership: 46.87% [Q3] → 48.25% (+1.38%) [Q4]

4% less funds holding

Funds holding: 197 [Q3] → 189 (-8) [Q4]

22% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 36

29% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 73

100% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 0 (-2) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$25
22%
upside
Avg. target
$30
46%
upside
High target
$35
70%
upside

2 analyst ratings

positive
0%
neutral
100%
negative
0%
Piper Sandler
David Westenberg
22%upside
$25
Neutral
Maintained
6 Mar 2024
UBS
Dan Leonard
70%upside
$35
Neutral
Initiated
7 Dec 2023

Financial journalist opinion